skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Amino acid-responsive Crohn's disease: a case study

Case report

(7738) Views  (1148) Full article downloads

Authors: Alvin Stein, Marty Hinz, Thomas Uncini

Published Date December 2010 Volume 2010:3 Pages 171 - 177
DOI: http://dx.doi.org/10.2147/CEG.S15340

Alvin Stein1, Marty Hinz2, Thomas Uncini3
1Stein Orthopedic Associates, Plantation, FL, USA; 2Clinical Research, NeuroResearch Clinics Inc., Cape Coral, FL, USA; 3Laboratory, Fairview Regional Medical Center-Mesabi, Hibbing, MN, USA

Purpose: This paper reviews the clinical course of a case of severe Crohn's disease and discusses the scientific ramifications of a novel treatment approach.
Patients and methods: A case study of a 37-year-old male with a 22-year history of Crohn's disease whose clinical course had experienced no sustained remissions. The patient was treated with a protocol that utilized serotonin and dopamine amino acid precursors administered under the guidance of organic cation transporter assay interpretation.
Results: Within 5 days of achieving the necessary balance of serotonin and dopamine, the patient experienced remission of symptoms. This remission has been sustained without the use of any Crohn's disease medications.
Conclusion: In Crohn's disease, it is known that there is an increase of both synthesis and tissue levels of serotonin in specific locations. It is asserted that this is prima facie evidence of a significant imbalance in the serotonin–dopamine system, leading to serotonin toxicity. The hypothesis formulated is that improperly balanced serotonin and dopamine transport, synthesis, and metabolism is a primary defect contributing to the pathogenesis of Crohn's disease.

Keywords: serotonin, dopamine, organic cation transporters, OCT




 

Other articles by Dr Marty Hinz

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Amino acid management of Parkinson’s disease: a case study
APRESS: apical regulatory super system, serotonin, and dopamine interaction
Monoamine depletion by reuptake inhibitors
Neurotransmitter testing of the urine: a comprehensive analysis
Relative nutritional deficiencies associated with centrally acting monoamines
The discrediting of the monoamine hypothesis
The dual-gate lumen model of renal monoamine transport
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”


Readers of this article also read:

Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population
Neurotransmitter testing of the urine: a comprehensive analysis
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
Amino acid management of Parkinson’s disease: a case study
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
APRESS: apical regulatory super system, serotonin, and dopamine interaction
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio